Gadavist Injection
Product Images NDC 50419-325

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Gadavist (NDC 50419-325). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bayer Healthcare Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Gadavist 01)

Chemical structure of gadobutrol, the active ingredient in Gadavist injection. The diagram shows the gadolinium ion (Gd3+) complexed with a macrocyclic ligand and multiple hydroxyl and carboxyl groups.*

FDA Label Image

65 mL Label (Gadavist 02)

Gadavist (gadobutrol) injection 1 mmol/mL, 65 mL sterile solution for intravenous use. The label states dose 0.1 mL/kg, Rx only, and indicates it is an imaging bulk package for direct infusion. It includes storage instructions, discard timing, and manufacturer information Bayer HealthCare Pharmaceuticals Inc., Germany.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.